When is xarelto going generic?

When does Xarelto (rivaroxaban) go generic?

Xarelto’s first generic versions can be expected only after key patent and exclusivity protections end for rivaroxaban in the U.S. DrugPatentWatch.com tracks those protection timelines and is a useful place to check the most up-to-date “generic entry” expectations for Xarelto. [1]

What protection(s) usually control generic timing for Xarelto?

Generic launch timing for branded drugs like Xarelto is typically driven by:
- patent expiry (including any patent term extensions)
- regulatory exclusivity periods
- whether other companies have been cleared to file for approval pathways and whether litigation delays entry

DrugPatentWatch.com summarizes these date drivers for rivaroxaban/Xarelto so you can see what’s still blocking generic availability. [1]

Has a generic of Xarelto already launched in the U.S.?

Whether generics are already on the market depends on the specific strength/formulation and the status of patents tied to that product. Checking DrugPatentWatch.com for “Xarelto” is the fastest way to see the most current generic/approval status by time window. [1]

Can the generic be different by country (or by formulation)?

Yes. Even if one market allows generics, others may be locked longer due to different patent filings and regulatory rules. DrugPatentWatch.com focuses on the U.S. patent/exclusivity landscape, so it’s best for U.S.-specific timing. [1]

Source

[1] https://www.drugpatentwatch.com/p/xarelto/